Lens Organoid Modeling Service
The study of the human lens, particularly the mechanisms underlying cataract formation, has been significantly constrained by the limitations of conventional research models. Animal models possess notable differences in lens physiology and genetics, leading to poor clinical translation, while primary human lens epithelial cell (hLEC) cultures suffer from rapid senescence and the loss of crucial in vivo characteristics. This has created a substantial barrier to understanding the etiology of lens disorders and developing effective anti-cataract therapeutics.
Creative Biolabs overcomes these challenges with a cutting-edge Lens Organoid Modeling Service. By directing the differentiation of human induced pluripotent stem cells (hiPSCs), we generate three-dimensional lens organoids that remarkably recapitulate the key developmental and structural features of the native human lens. This provides a powerful, human-specific platform to dissect disease mechanisms, screen novel compounds, and pioneer the next generation of therapies for cataracts and other lens-related disorders.
A High-Fidelity Reconstruction of the Human Lens
Our lens organoids are not simple spheroids; they are sophisticated, self-organizing micro-tissues that accurately model the unique biology and architecture of the human lens.
-
Authentic Cellular Composition and Structure: Our protocol guides hiPSCs to form organoids containing the two primary cell types of the lens in their correct anatomical arrangement:
- Lens Epithelial Cells (LECs): Forming an outer layer that expresses the critical marker PAX6.
- Differentiated Lens Fiber Cells: Comprising the core of the organoid, these cells express key crystallin proteins such as αA-crystallin (CRYAA) and exhibit the characteristic elongated morphology of mature fiber cells.
- Recapitulation of Lens Development: Our organoids mimic the crucial developmental process of fiber cell differentiation, providing a dynamic system to study both normal lens morphogenesis and the pathological changes that disrupt this process.
- Robustness and Reproducibility: We have established optimized, serum-free culture conditions that ensure the consistent and reproducible generation of high-quality lens organoids, making them a reliable and scalable platform for a wide range of research applications, including high-throughput screening.
A Validated Platform for Cataract Research and Beyond
Our human-centric models provide a powerful tool for investigating the most common cause of blindness worldwide.
-
Modeling Cataractogenesis: We can induce cataract-like phenotypes in our lens organoids using various stimuli. By exposing the organoids to stressors such as oxidative stress (e.g., with hydrogen peroxide), UV radiation, or chemical insults (e.g., with selenite), we can model the protein aggregation and cellular damage that lead to lens opacification. This provides a direct, quantifiable system to:
- Investigate the molecular pathways of cataract formation.
- Screen for novel anti-cataract compounds that can prevent or reverse opacity.
- Modeling Genetic and Congenital Cataracts: We utilize iPSCs derived from patients with inherited cataracts or employ CRISPR-Cas9 gene editing to introduce specific mutations (e.g., in crystallin genes). This allows for the precise study of how genetic defects disrupt lens development and lead to early-onset cataracts.
- Toxicology and Drug Safety Screening: The lens is susceptible to off-target drug effects. Our organoid platform provides a human-relevant system to assess the potential for candidate therapeutics to induce cataracts, offering crucial safety data early in the drug development pipeline.
Our Streamlined Project Workflow
Bringing Clarity to Lens Research. Focusing on the Future of Ocular Health.
Leverage the power of human-specific lens organoids to gain unparalleled insights into cataract formation and accelerate your journey toward clinical solutions.
Consult Our Ocular Modeling Specialists
Reference
- Duot, Matthieu et al. "Eye Lens Organoids Made Simple: Characterization of a New Three-Dimensional Organoid Model for Lens Development and Pathology." Cells vol. 12,20 2478. 18 Oct. 2023, doi:10.3390/cells12202478. Distributed under Open Access License CC BY 4.0 without modification.
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Rat Muller Cell (Cat#: NCL2110P040)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
